Market Research Logo

North America Microbiology Culture Market Outlook to 2024

North America Microbiology Culture Market Outlook to 2024

Summary

GlobalData’s new report, North America Microbiology Culture Market Outlook to 2024, provides key market data on the North America Microbiology Culture market. The report provides value, in millions of US dollars within market segments - Bacterial Identification & Susceptibility Testing, Blood Culture, Immunological Culture Identification, Microbiology Analyzers, Mycobacteria Culture, Mycology Culture and Parasitology Culture

The report also provides company shares and distribution shares data for each of these market segments, and global corporate-level profiles of the key market participants. Based on the availability of data for the particular market and country, information related to pipeline products, news and deals is available in the report.

Extensive interviews are conducted with key opinion leaders (KOLs), physicians and industry experts to validate the market size, company share and distribution share data and analysis.

Scope

  • Market size and company share data for Microbiology Culture market segments - Bacterial Identification & Susceptibility Testing, Blood Culture, Immunological Culture Identification, Microbiology Analyzers, Mycobacteria Culture, Mycology Culture and Parasitology Culture
  • Annualized market revenues (USD million) and volume (units) data for each of the market segments. Data is provided from 2010 to 2017 and forecast to 2024.
  • 2017 company shares and distribution shares data for each of the market segments.
  • Global corporate-level profiles of key companies operating within the North America Microbiology Culture market.
  • Key players covered include Becton Dickinson and Co, bioMerieux SA, Bio-Rad Laboratories Inc and Thermo Fisher Scientific Inc.
Reasons to buy
  • Develop business strategies by identifying the key market segments poised for strong growth in the future.
  • Develop market-entry and market expansion strategies.
  • Design competition strategies by identifying who-stands-where in the market.
  • Develop investment strategies by identifying the key market segments expected to register strong growth in the near future.
  • What are the key distribution channels and what’s the most preferred mode of product distribution - Identify, understand and capitalize.


1 Table of Contents
1.1 List of Tables
1.2 List of Figures
2 Introduction
2.1 What Is This Report About?
2.2 Microbiology Culture Market Segmentation
2.3 Definitions of Markets Covered in the Report
3 Microbiology Culture Market, North America
3.1 Microbiology Culture Market, North America, Revenue ($m), 2010-2024
3.2 Microbiology Culture Market, North America, Category Comparison by Revenue ($m), 2010-2024
3.3 Microbiology Culture Market, North America, Revenue ($m), 2010-2017
3.4 Microbiology Culture Market, North America, Revenue ($m), 2017-2024
3.5 Microbiology Culture Market, North America, Company Share by Revenue ($m), 2017
4 Microbiology Culture Market, Canada
4.1 Microbiology Culture Market, Canada, Revenue ($m), 2010-2017
4.2 Microbiology Culture Market, Canada, Revenue ($m), 2017-2024
4.2.1 Bacterial Identification & Susceptibility Testing Market, Canada, Revenue ($m), by Segment, 2010-2017
4.2.2 Microbiology Analyzers Market, Canada, Revenue ($m), by Segment, 2010-2017
4.2.3 Bacterial Identification & Susceptibility Testing Market, Canada, Revenue ($m), by Segment, 2017-2024
4.2.4 Microbiology Analyzers Market, Canada, Revenue ($m), by Segment, 2017-2024
4.3 Microbiology Culture Market, Canada, Distribution Share by Revenue ($m), 2017
4.4 Microbiology Culture Market, Canada, Company Share by Revenue ($m), 2017
5 Microbiology Culture Market, Mexico
5.1 Microbiology Culture Market, Mexico, Revenue ($m), 2010-2017
5.2 Microbiology Culture Market, Mexico, Revenue ($m), 2017-2024
5.2.1 Bacterial Identification & Susceptibility Testing Market, Mexico, Revenue ($m), by Segment, 2010-2017
5.2.2 Microbiology Analyzers Market, Mexico, Revenue ($m), by Segment, 2010-2017
5.2.3 Bacterial Identification & Susceptibility Testing Market, Mexico, Revenue ($m), by Segment, 2017-2024
5.2.4 Microbiology Analyzers Market, Mexico, Revenue ($m), by Segment, 2017-2024
5.3 Microbiology Culture Market, Mexico, Distribution Share by Revenue ($m), 2017
5.4 Microbiology Culture Market, Mexico, Company Share by Revenue ($m), 2017
6 Microbiology Culture Market, United States
6.1 Microbiology Culture Market, United States, Revenue ($m), 2010-2017
6.2 Microbiology Culture Market, United States, Revenue ($m), 2017-2024
6.2.1 Bacterial Identification & Susceptibility Testing Market, United States, Revenue ($m), by Segment, 2010-2017
6.2.2 Microbiology Analyzers Market, United States, Revenue ($m), by Segment, 2010-2017
6.2.3 Bacterial Identification & Susceptibility Testing Market, United States, Revenue ($m), by Segment, 2017-2024
6.2.4 Microbiology Analyzers Market, United States, Revenue ($m), by Segment, 2017-2024
6.3 Microbiology Culture Market, United States, Distribution Share by Revenue ($m), 2017
6.4 Microbiology Culture Market, United States, Company Share by Revenue ($m), 2017
7 Overview of Key Companies in North America Microbiology Culture Market
7.1 bioMerieux SA
7.1.1 Company Overview
7.2 Becton Dickinson and Co
7.2.1 Company Overview
7.3 Thermo Fisher Scientific Inc
7.3.1 Company Overview
7.4 Beckman Coulter Inc
7.4.1 Company Overview
7.5 Bio-Rad Laboratories Inc
7.5.1 Company Overview
7.6 Himedia Laboratories Pvt Ltd
7.6.1 Company Overview
8 Microbiology Culture Market Pipeline Products
9 Recent Developments
9.1 Corporate Communications
9.1.1 Sep 22, 2017: Neogen announces management change
9.1.2 Aug 24, 2017: LabCorp Names Nationally Recognized Health-Policy Expert Dr. Brian Caveney As Enterprise-Wide Chief Medical Officer
9.1.3 Jul 18, 2017: LabCorp’s William Hanlon Appointed to Governing Committee of the National Evaluation System for health Technology Coordinating Center
9.1.4 Jul 17, 2017: Neogen names new CEO
9.1.5 May 17, 2017: Advanced Instruments Announces Appointment of Byron Selman as CEO
9.1.6 Apr 11, 2017: Organovo Announces CEO Transition
9.1.7 Mar 29, 2017: LabCorp Promotes Executive Gary Huff to CEO of LabCorp Diagnostics, One of the Company’s Two Primary Business Segments
9.1.8 Mar 01, 2017: Thermo Fisher Scientific Elects New Director to Board
9.1.9 Jan 26, 2017: Metabolon Announces Changes to Executive Leadership Team
9.1.10 Dec 14, 2016: Beckman Coulter appoints IT Product Manager for Northern Europe
9.1.11 Dec 07, 2016: Neogen names chief science officer
9.2 Financial Announcements
9.2.1 Nov 01, 2017: Quidel Reports Third Quarter 2017 Financial Results
9.2.2 Oct 25, 2017: LabCorp Announces Record Third Quarter Results and Increases 2017 Guidance
9.2.3 Oct 25, 2017: Thermo Fisher Scientific Reports Third Quarter 2017 Results
9.2.4 Oct 04, 2017: Organovo Announces Preliminary Fiscal Second-Quarter Total Revenue; Company Restructures to Improve Operational Efficiency
9.2.5 Sep 19, 2017: Neogen reports 21% net income increase
9.2.6 Aug 09, 2017: Organovo Announces Fiscal First-Quarter 2018 Results; Company Affirms Full-Year Fiscal 2018 Outlook
9.2.7 Jul 26, 2017: LabCorp Announces Record Results in the Second Quarter of 2017 and Increases 2017 Guidance
9.2.8 Jul 26, 2017: Thermo Fisher Scientific Reports Second Quarter 2017 Results
9.2.9 Jul 26, 2017: Quidel Reports Second Quarter 2017 Financial Results
9.2.10 Jul 18, 2017: Neogen reports record revenues and earnings
9.2.11 Jul 12, 2017: Premaitha Health: Investment Agreement Extension with Thermo Fisher Scientific
9.2.12 Jun 07, 2017: Organovo Announces Fiscal Fourth-Quarter and Full-Year 2017 Results; Company Issues Full-Year Fiscal 2018 Outlook
9.2.13 Jun 01, 2017: Announcement on submission of the Clinical Trial Plan Notification for phase I clinical trial of Oncolytic virus HF10 against pancreatic cancer in Japan
9.2.14 Apr 26, 2017: Thermo Fisher Scientific Reports First Quarter 2017 Results
9.2.15 Apr 25, 2017: Laboratory Corporation of America Holdings Announces 2017 First Quarter Results and Updates 2017 Guidance
9.2.16 Apr 24, 2017: Quidel Reports First Quarter 2017 Financial Results
9.2.17 Mar 22, 2017: Verona Pharma Enters Global Strategic Clinical Development Services Agreement with QuintilesIMS for RPL554
9.2.18 Mar 21, 2017: Neogen reports 24% increase in net income
9.2.19 Mar 13, 2017: DJO Global Announces The Launch of The AltiVate Anatomic Shoulder System
9.2.20 Feb 16, 2017: Laboratory Corporation of America Holdings Announces Record 2016 Fourth Quarter and Full Year Results and Provides 2017 Guidance
9.2.21 Feb 09, 2017: Organovo Announces Fiscal Third-Quarter 2017 Results
9.2.22 Feb 08, 2017: Quidel Reports Fourth Quarter and Full Year 2016 Financial Results
9.2.23 Jan 31, 2017: Thermo Fisher Scientific Reports Fourth Quarter and Full Year 2016 Results
9.2.24 Jan 18, 2017: Synthetic Biologics Confirms Key Features of Pivotal Phase 2b/3 Trial of SYN-010 Pursuant to Consultations with FDA
9.2.25 Jan 18, 2017: Teva Receives FDA Approval for VANTRELA ER (Hydrocodone Bitartrate) Extended-Release Tablets [CII] Formulated with Proprietary Abuse Deterrence Technology
9.2.26 Jan 18, 2017: Dermata Therapeutics Announces Initiation of Treatment in a Phase 2 Acne Rosacea Clinical Study
9.2.27 Jan 17, 2017: Encore Dermatology Announces Launch of Tridesilon (desonide) Cream, 0.05%
9.2.28 Jan 16, 2017: ORYZON Announces Expansion of its Scientific Advisory Board
9.2.29 Jan 06, 2017: Quidel Announces Preliminary Revenue for Fourth Quarter 2016
9.2.30 Dec 24, 2016: Genor Biopharma's PD-1 antibody Genolimzumab got clinical trial approval from the CFDA
9.2.31 Dec 21, 2016: Notice Concerning the Phase I Clinical Study on NC-6004 for Patients with Head and Neck Cancer in Japan
9.2.32 Dec 21, 2016: Neogen reports 23% increase in net income
9.3 Legal And Regulatory
9.3.1 Jun 15, 2017: Oxford Immunotec Announces Favorable Claim Construction Ruling in Patent Infringement Litigation
9.3.2 Jan 23, 2017: ISO 17025 Accreditation for Microbiology Manufacturing Site Offers Increased Confidence to Microbiology Testing Laboratories
9.3.3 Nov 29, 2016: C3 Jian announces names change to C3J Therapeutics
9.3.4 Nov 29, 2016: C3 Jian Announces Corporate Name Change and Expansion of Management Team
9.4 Other Significant Developments
9.4.1 Sep 25, 2017: LabCorp Objects to Proposed PAMA 2018 Medicare Payment Rates for Clinical Laboratory Tests; Calls for Delay in Implementation to Avoid Significant Harm to Medicare Beneficiaries
9.4.2 Jul 18, 2017: BD Transforms Microbiology Urine Testing
9.4.3 Jan 23, 2017: Quidel Announces Modification of Revenue Reporting Categories
9.5 Product News
9.5.1 Apr 05, 2017: Pall Fortebio Launches the Octet Red96E System For More Versatile Biologics Characterization
9.6 Strategy And Business Planning
9.6.1 Apr 21, 2017: Covance to Expand Large-Molecule Development Capabilities in the UK
10 Appendix
10.1 Research Methodology
10.1.1 Coverage
10.1.2 Secondary Research
10.1.3 Primary Research
10.1.4 Market Modeling and Forecasting
10.1.5 Company Share Analysis
10.1.6 Distribution Share Analysis
10.1.7 Benchmarking
10.2 GlobalData Consulting
10.3 Contact Us
10.4 Disclaimer
1.1 List of Tables
Table 1: Microbiology Culture Market, Cross Country Comparison, North America, Revenue ($m), USD Constant, 2010-2024
Table 2: Microbiology Culture Market, North America, Category Comparison by Revenue ($m), USD Constant, 2010-2024
Table 3: Microbiology Culture Market, North America, Revenue ($m), Historic, USD Constant, 2010-2017
Table 4: Microbiology Culture Market, North America, Revenue ($m), Forecast, USD Constant, 2017-2024
Table 5: Microbiology Culture Market, North America, Company Share by Revenue ($m), USD Constant, 2017
Table 6: Microbiology Culture Market, Canada, Revenue ($m), USD Constant, Historic, 2010-2017
Table 7: Microbiology Culture Market, Canada, Revenue ($m), USD Constant, Forecast, 2017-2024
Table 8: Bacterial Identification & Susceptibility Testing Market, Canada, Revenue ($m), USD Constant, Historic, 2010-2017
Table 9: Microbiology Analyzers Market, Canada, Revenue ($m), USD Constant, Historic, 2010-2017
Table 10: Bacterial Identification & Susceptibility Testing Market, Canada, Revenue ($m), USD Constant, Forecast, 2017-2024
Table 11: Microbiology Analyzers Market, Canada, Revenue ($m), USD Constant, Forecast, 2017-2024
Table 12: Microbiology Culture Market, Canada, Distribution Share by Revenue ($m), USD Constant, 2017
Table 13: Microbiology Culture Market, Canada, Company Share by Revenue ($m), USD Constant, 2017
Table 14: Microbiology Culture Market, Mexico, Revenue ($m), USD Constant, Historic, 2010-2017
Table 15: Microbiology Culture Market, Mexico, Revenue ($m), USD Constant, Forecast, 2017-2024
Table 16: Bacterial Identification & Susceptibility Testing Market, Mexico, Revenue ($m), USD Constant, Historic, 2010-2017
Table 17: Microbiology Analyzers Market, Mexico, Revenue ($m), USD Constant, Historic, 2010-2017
Table 18: Bacterial Identification & Susceptibility Testing Market, Mexico, Revenue ($m), USD Constant, Forecast, 2017-2024
Table 19: Microbiology Analyzers Market, Mexico, Revenue ($m), USD Constant, Forecast, 2017-2024
Table 20: Microbiology Culture Market, Mexico, Distribution Share by Revenue ($m), USD Constant, 2017
Table 21: Microbiology Culture Market, Mexico, Company Share by Revenue ($m), USD Constant, 2017
Table 22: Microbiology Culture Market, United States, Revenue ($m), USD Constant, Historic, 2010-2017
Table 23: Microbiology Culture Market, United States, Revenue ($m), USD Constant, Forecast, 2017-2024
Table 24: Bacterial Identification & Susceptibility Testing Market, United States, Revenue ($m), USD Constant, Historic, 2010-2017
Table 25: Microbiology Analyzers Market, United States, Revenue ($m), USD Constant, Historic, 2010-2017
Table 26: Bacterial Identification & Susceptibility Testing Market, United States, Revenue ($m), USD Constant, Forecast, 2017-2024
Table 27: Microbiology Analyzers Market, United States, Revenue ($m), USD Constant, Forecast, 2017-2024
Table 28: Microbiology Culture Market, United States, Distribution Share by Revenue ($m), USD Constant, 2017
Table 29: Microbiology Culture Market, United States, Company Share by Revenue ($m), USD Constant, 2017
Table 30: Microbiology Culture Market Pipeline Products
Table 31: Total Number of Primary Research Participants, In Vitro Diagnostics Market, by Country
1.2 List of Figures
Figure 1: Microbiology Culture Market, Cross Country Comparison, North America, Revenue ($m), USD Constant, 2010-2024
Figure 2: Microbiology Culture Market, North America, Category Comparison by Revenue ($m), USD Constant, 2010-2024
Figure 3: Microbiology Culture Market, North America, Revenue ($m), Historic, USD Constant, 2010-2017
Figure 4: Microbiology Culture Market, North America, Revenue ($m), Forecast, USD Constant, 2017-2024
Figure 5: Microbiology Culture Market, North America, Company Share (%) 2017
Figure 6: Microbiology Culture Market, Canada, Revenue ($m), USD Constant, Historic, 2010-2017
Figure 7: Microbiology Culture Market, Canada, Revenue ($m), USD Constant, Forecast, 2017-2024
Figure 8: Bacterial Identification & Susceptibility Testing Market, Canada, Revenue ($m), USD Constant, Historic, 2010-2017
Figure 9: Microbiology Analyzers Market, Canada, Revenue ($m), USD Constant, Historic, 2010-2017
Figure 10: Bacterial Identification & Susceptibility Testing Market, Canada, Revenue ($m), USD Constant, Forecast, 2017-2024
Figure 11: Microbiology Analyzers Market, Canada, Revenue ($m), USD Constant, Forecast, 2017-2024
Figure 12: Microbiology Culture Market, Canada, Company Share (%) 2017
Figure 13: Microbiology Culture Market, Mexico, Revenue ($m), USD Constant, Historic, 2010-2017
Figure 14: Microbiology Culture Market, Mexico, Revenue ($m), USD Constant, Forecast, 2017-2024
Figure 15: Bacterial Identification & Susceptibility Testing Market, Mexico, Revenue ($m), USD Constant, Historic, 2010-2017
Figure 16: Microbiology Analyzers Market, Mexico, Revenue ($m), USD Constant, Historic, 2010-2017
Figure 17: Bacterial Identification & Susceptibility Testing Market, Mexico, Revenue ($m), USD Constant, Forecast, 2017-2024
Figure 18: Microbiology Analyzers Market, Mexico, Revenue ($m), USD Constant, Forecast, 2017-2024
Figure 19: Microbiology Culture Market, Mexico, Company Share (%) 2017
Figure 20: Microbiology Culture Market, United States, Revenue ($m), USD Constant, Historic, 2010-2017
Figure 21: Microbiology Culture Market, United States, Revenue ($m), USD Constant, Forecast, 2017-2024
Figure 22: Bacterial Identification & Susceptibility Testing Market, United States, Revenue ($m), USD Constant, Historic, 2010-2017
Figure 23: Microbiology Analyzers Market, United States, Revenue ($m), USD Constant, Historic, 2010-2017
Figure 24: Bacterial Identification & Susceptibility Testing Market, United States, Revenue ($m), USD Constant, Forecast, 2017-2024
Figure 25: Microbiology Analyzers Market, United States, Revenue ($m), USD Constant, Forecast, 2017-2024
Figure 26: Microbiology Culture Market, United States, Company Share (%) 2017

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook

Share this report